A Phase 2 Study of BB102 in Patients With Hepatocellular Carcinoma

Clinical trial NCT07239986 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07239986
Sponsor: Broadenbio Ltd., Co.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma (HCC)

Start date: 2025-12-01
Primary completion: 2027-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.